Appointment reflects Glauconix Biosciences' commitment to business and organizational excellence as they continue on their trajectory to become the leading developer of ex vivo-like 3D human tissue models for accelerating therapeutic innovation and drug discovery
In Vitro Approach Provides Predictive Platform for Human-Based Drug Discovery
Attracting Top Talent Will Enable VMS to Continue Expanding Its Clinical Nurse Educator Programs to Help More Patients Served by the Biopharma Industry
Flexible electronics and smart bandages are key to cost savings in the future of advanced wound care
North America accounted for the largest share of the vaccines market with its well-established vaccination program.
Trial Designed to Test Camsirubicin Against Doxorubicin as First-Line Therapy
Regis Technologies, a contract development and manufacturing organization for small molecule active pharmaceutical ingredients, announces a new Solid State Chemistry service.